Aphria CEO says company had ‘gargantuan’ quarter despite lowered ask

Aphria CEO says company had ‘gargantuan’ quarter despite lowered ask

Aphria CEO Irwin Simon joins ‘Closing Bell’ to focus on relating to the lowered ask for cannabis in Canada as pandemic lockdowns hit gross sales. The stock is peaceable up…

Aphria duration in-between CEO: Curbing Canada’s Cannabis Shaded Market | Angry Money | CNBC

Aphria duration in-between CEO: Curbing Canada’s Cannabis Shaded Market | Angry Money | CNBC

Jim Cramer chats with Aprhia duration in-between CEO Irwin Simon coming off the cannabis company’s shock earnings document and where the corporate is finding instruct in the prison weed industry….

Barneys Contemporary York CEO Daniella Vitale on cannabis paraphernalia

Barneys Contemporary York CEO Daniella Vitale on cannabis paraphernalia

Danielle Vitale, president and CEO of Barneys Contemporary York, joins “Verbalize on the Avenue” to keep up a correspondence about the corporate’s resolution to delivery promoting high-end cannabis items in…

The sights and sounds from the cannabis conference in Las Vegas

The sights and sounds from the cannabis conference in Las Vegas

MJBizCon, the cannabis trade’s supreme and oldest trade conference, is taking place in Las Vegas. With CNBC’s Melissa Lee and the Instant Cash merchants, Carter Payment, Courtney Garcia, Man Adami…

Immune Gut & Brain
Curaleaf chairman on the global growth of hashish availability

Curaleaf chairman on the global growth of hashish availability

Curaleaf executive chairman Boris Jordan joins “Verbalize on the Facet motorway” to debate the corporate’s growth into Europe. For entry to live and queer video from CNBC subscribe to CNBC…

Tilray CEO: Alternatives in clinical cannabis are colossal

Tilray CEO: Alternatives in clinical cannabis are colossal

Tilray’s inventory is up this day, but mute down 80 percent from a February high. CNBC’s Frank Holland reports on his dialog with Tilray CEO Irwin Simon about the corporate’s…

Aurora Cannabis earnings miss revenue expectations

Aurora Cannabis earnings miss revenue expectations

Aurora Cannabis CEO Miguel Martinjoins Closing Bell to talk about his company’s Q4 earnings. He is assured the company is on the run to profitability. For access to are dwelling…

Trulieve CEO on multi-pronounce operators blockbuster quarter and the long term of marijuana

Trulieve CEO on multi-pronounce operators blockbuster quarter and the long term of marijuana

Kim Rivers, Trulieve CEO, discusses the company’s blowout earnings document. With CNBC’s Courtney Reagan and the Quick Money traders, Man Adami, Tim Seymour, Dan Nathan and Steve Grasso. For safe…

Cannabis gross sales in New Jersey could per chance high $2 billion by 2025: Overview analyst

Cannabis gross sales in New Jersey could per chance high $2 billion by 2025: Overview analyst

CNBC’s “Mutter Alley” team discusses what’s next for hashish stocks as weed turns into legalized in more states at some stage within the nation with Vivien Azer of Cowen. For…

The organization ‘Trim Approaches to Marijuana’ desires America to rethink legalizing cannabis

The organization ‘Trim Approaches to Marijuana’ desires America to rethink legalizing cannabis

Kevin Sabet, president and CEO of Trim Approaches to Marijuana, an organization main the lobbying effort against legalization of the drug, joins “Suppose Field” to mark why his organization is…